Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3580760
Max Phase: Preclinical
Molecular Formula: C30H29Cl3N10O4
Molecular Weight: 663.53
Molecule Type: Small molecule
Associated Items:
ID: ALA3580760
Max Phase: Preclinical
Molecular Formula: C30H29Cl3N10O4
Molecular Weight: 663.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CCN(C(=O)C[C@H](NC(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)c2nc(-c3ccc4[nH]c(=O)cc(O)c4c3)c(Cl)[nH]2)CC1.Cl
Standard InChI: InChI=1S/C30H28Cl2N10O4.ClH/c1-40-8-10-41(11-9-40)27(46)14-22(35-25(44)7-3-17-12-19(31)4-6-23(17)42-16-33-38-39-42)30-36-28(29(32)37-30)18-2-5-21-20(13-18)24(43)15-26(45)34-21;/h2-7,12-13,15-16,22H,8-11,14H2,1H3,(H,35,44)(H,36,37)(H2,34,43,45);1H/b7-3+;/t22-;/m0./s1
Standard InChI Key: PKVVLVYNVQAUEP-BWHJXNDYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 663.53 | Molecular Weight (Monoisotopic): 662.1672 | AlogP: 2.94 | #Rotatable Bonds: 8 |
Polar Surface Area: 178.02 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.61 | CX Basic pKa: 7.25 | CX LogP: 0.78 | CX LogD: 0.66 |
Aromatic Rings: 5 | Heavy Atoms: 46 | QED Weighted: 0.18 | Np Likeness Score: -1.35 |
1. Hu Z, Wong PC, Gilligan PJ, Han W, Pabbisetty KB, Bozarth JM, Crain EJ, Harper T, Luettgen JM, Myers JE, Ramamurthy V, Rossi KA, Sheriff S, Watson CA, Wei A, Zheng JJ, Seiffert DA, Wexler RR, Quan ML.. (2015) Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' Moiety., 6 (5): [PMID:26005539] [10.1021/acsmedchemlett.5b00066] |
Source(1):